TrialAmerican journal of hematology2015

Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease.

Ari Zimran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.